2,4,6-trihydroxyacetophenone has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bao, XQ; Cao, SN; Hu, JP; Li, Y; Wang, XL; Wang, YD; Xu, S; Yu, SS; Yu, WW; Zhang, D | 1 |
Haro, JM; Jones, JW; Li, B; Tran, A; Wan, L; Xu, Z | 1 |
2 other study(ies) available for 2,4,6-trihydroxyacetophenone and Disease Models, Animal
Article | Year |
---|---|
A Novel Parkinson's Disease Drug Candidate with Potent Anti-neuroinflammatory Effects through the Src Signaling Pathway.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Drug Discovery; Male; Mice, Inbred ICR; Mice, Transgenic; Neuroprotective Agents; Parkinson Disease, Secondary; Phloroglucinol; Serine; Signal Transduction; src-Family Kinases | 2016 |
Lithium Hydroxide Hydrolysis Combined with MALDI TOF Mass Spectrometry for Rapid Sphingolipid Detection.
Topics: Acetophenones; Animals; Chromatography, High Pressure Liquid; Diet, High-Fat; Disease Models, Animal; Female; Hydrolysis; Lithium Compounds; Liver; Mice, Inbred C57BL; Obesity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sphingolipids; Workflow | 2021 |